The Brazilian state of Bahia signs deal for Russia's vaccine against Covid-19

The Brazilian state of Bahia has signed an agreement to conduct Phase III clinical trials of Russia's Sputnik V vaccine against COVID-19 and plans to buy 50 million doses to market in Brazil, officials have said. The Russian vaccine is being developed by Moscow's Gamaleya Research Institute and marketed by the Russian Direct Investment Fund (RDIF), which last month also entered an agreement with the Brazilian state of Paraná to test and produce the vaccine. Russia will sell up to 50 million doses of the Sputnik-V vaccine to Bahia state, RDIF said in a statement.